Office of Research & Development |
|
Project Number: | I01BX004841-01A1 |
Title: | Preclinical investigation of PI3K inhibition and immune checkpoint blockade combination therapy for treatment of Merkel cell carcinoma using humanized mouse models |
Principal Investigator: | Ling Gao |
Location: | Long Beach, CA |
Congressional District Code: | 47 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | April 2020 - March 2024 |
FY 2024 Funding Amount: | $90,675 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |